Skip to main content
Market intelligence
BLTEHealthcare

Belite Bio Inc ADR insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 12, 2026Hao-Yuan ChuangChief Financial OfficerSale367$180.35$66,187
Aug 12, 2026Yu-Hsin LinChief Executive OfficerSale365$180.35$65,827
Jun 18, 2026Hendrik Peter SchollChief Medical OfficerSale10,000$145.24$1,452,435